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Baldassarre, Damiano, Mauro Amato, Carlo Pal-
ombo, Carmela Morizzo, Linda Pustina, and Cesare R.
Sirtori. Time course of forearm arterial compliance changes
during reactive hyperemia. Am J Physiol Heart Circ Physiol
281: H1093–H1103, 2001.—Ultrasonic studies have shown
that arterial compliance increases after prolonged ischemia.
The objective of the present study was to develop an alter-
native plethysmographic method to investigate compliance,
exploring validity and clinical applicability. Forearm pulse
volume (FPV) and blood pressure (BP) were used to establish
the FPV-BP relationship. Forearm arterial compliance (FAC)
was measured, and the area under the FAC-BP curve
(FACAUC) was determined. The time course curve of compli-
ance changes during reactive hyperemia was obtained by
continuous measurements of FACAUC for 20 s before and for
300 s after arterial occlusion. This technique allows us to
effectively assess compliance changes during reactive hyper-
emia. Furthermore, the selected measurement protocol indi-
cated the necessity for continuous measurements to detect
“true” maximal FACAUC changes. On multivariate analysis,
preischemic FACAUC was mainly affected by sex, peak
FACAUC was affected by sex and systolic BP, percent changes
were affected by plasma high-density and low-density lipo-
protein cholesterol, peak time was affected by age and body
mass index, and descent time was affected by plasma triglyc-
eride levels. The proposed technique is highly sensitive and
well comparable with the generally accepted echotracking
system. It may thus be considered as an alternative tool to
detect and monitor compliance changes induced by arterial
occlusion.
plethysmography; endothelial dysfunction
ARTERIAL COMPLIANCE IS BECOMING an increasingly impor-
tant clinical parameter. When reduced, it may be a
potentially useful indicator of the presence of arterial
disease (30). Functional changes in the arterial wall
leading to reduced compliance may precede the onset of
clinically apparent disease (clinical manifestations
and/or arterial wall structural changes) and may iden-
tify individuals at risk before disease onset. A variety
of techniques evaluating different arterial wall func-
tions (arterial diameter, blood flow, and cross-sectional
area) have been developed to measure this parameter
(3, 10, 13, 14, 31). Some of them allow the assessment
of large vessel compliance only, whereas others allow
the assessment of large and small vessel compliance,
i.e., resulting from changes at the arteriolar level. At
present, there is no consensus as to the “best” method
for measuring peripheral compliance, but it is impor-
tant to note that a number of available techniques do
not take into account that compliance is a pressure-
dependent parameter.
Independent of the technique, most of the studies
published so far have generally shown that differences
among cases are not detectable in unstimulated condi-
tions but become clearly evident when measured after
the administration of organic nitrates (endothelium-
independent vasodilators) or cholinergic stimuli (endo-
thelium-dependent vasodilators). Because these vaso-
active substances must be administered via a catheter
inserted into the brachial artery, this may become an
invasive, costly, and time-consuming procedure, asso-
ciated with potential risk and discomfort, thus severely
limiting clinical applicability.
A possible alternative endothelium-dependent stim-
ulus useful for identifying endothelial dysfunction in
humans in a noninvasive way is reactive hyperemia
(20, 27, 34). This stimulus, obtained with a more or less
prolonged arterial occlusion, induces an increased flow
(27, 34) causing endothelium-mediated vasodilatation
(20, 36) and increased compliance (17, 19).
In studies evaluating arterial compliance changes
during reactive hyperemia, the postischemic modifica-
tions have been generally measured at arbitrary time
intervals of 20–30 s, and the time course curve of
postischemic variations was generally ignored.
We propose a new plethysmographic method use-
ful for measuring forearm arterial compliance (FAC)
[the area under the FAC-blood pressure (BP) curve
(FACAUC)]. This method, which takes into account non-
linear compliance/BP dependence and allows continu-
ous measurements, was previously validated by evaluat-
ing its capacity to detect acetylcholine-induced changes
as well as differences between hypercholesterolemic pa-
tients and age- and sex-matched normal controls (2).
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The present study was designed to 1) evaluate the
ability of this method to appreciate FACAUC changes
occurring during reactive hyperemia; 2) assess the
validity of the aforementioned noncontinuous postis-
chemic compliance measurement procedures; 3) fur-
ther validate the plethysmographic method vis-a`-vis
measurements made with an echotracking device; 4)
assess whether apart from the maximal compliance
changes, known to be impaired in the presence of
several pathological conditions (e.g., hypercholesterol-
emia) (17), other time-dependent postischemic param-
eters may be related to plasma lipids and other labo-
ratory and clinical variables.
METHODS
Subjects. The experimental group consisted of 95 volun-
teers (53 men and 42 women, age range: 18–80 yr) recruited
from the medical staff of our institutions as well as from
patients attending the E. Grossi Paoletti Center for the
Study of Metabolic Diseases. In view of the methodological
nature of the study, subjects were enrolled without any
specific selection criteria. Oral informed consent was ob-
tained from all subjects, and the study was approved by the
Internal Review Board. The characteristics of the studied
population are shown in Table 1.
At the time of the investigation, 44 subjects (47.3%) were
found to be normolipidemics [low-density lipoprotein choles-
terol (LDL-C) # 130 mg/dl], 17 subjects (18.3%) had border-
line hypercholesterolemia (130 , LDL-C # 160 mg/dl), and
32 subjects (34.4%) had clear-cut hypercholesterolemia
(LDL-C . 160 mg/dl).
Sixteen percent of the patients were found to be moder-
ately hypertensive [systolic BP (SBP) . 160 or diastolic BP
(DBP) . 90]; two patients were suffering from cardiovascular
diseases (myocardial infarction or angina), three patients
from peripheral vascular disease, and two patients had had
at least one acute cerebrovascular event [transient ischemic
attack (TIA) or stroke]. The other subjects were free from
established atherosclerotic lesions (no myocardial infarction,
angina, claudication, or cerebrovascular ischemia) or from
arterial occlusive disease (no murmurs or decreased vascular
pulses and absence of ultrasound-detected evidence of overt
carotid atherosclerosis: mean intima-media thickness , 1.3
mm and single maximum intima-media thickness , 1.5 mm)
(39). In addition, none had diabetes mellitus and, excluding
the seven patients with cardio-, cerebro-, or peripheral vas-
cular disease, none had been taking, in the 2 mo before the
study, lipid-lowering, antihypertensive, or any other medica-
tion known to affect arterial distensibility. In the whole
group there were 27 smokers (29%); they abstained from
smoking for the 12 h before the test.
Twelve additional normal subjects (normolipidemic, nor-
motensive, nonsmokers) were enrolled to examine whether
the shape of the time course postischemic curve might de-
pend on ischemic duration. These underwent two complete
compliance examinations separated by a 1-h interval carried
out by performing two different durations of ischemia (see
below). The protocol was decided after a preliminary study in
healthy subjects (n 5 6), which confirmed that 15 min are
sufficient to obtain a complete vessel recovery after either 3
or 12 min of arterial occlusion (data not shown). For the
assessment of repeatability of the methodology, nine more
normal subjects underwent two plethysmographic investiga-
tions 1 mo apart.
Finally, an additional group of 12 subjects was recruited,
without any specific selection criteria, to evaluate the agree-
ment between the plethysmographic method proposed here
and an echotracking device, the technological “gold standard”
for arterial compliance measurements (35). The ultrasound
images were taken from longitudinal views of the radial
arteries as close as possible to the side were the strain gauge
was positioned. All the measurements of arterial wall move-
ments were performed automatically by the ultrasound in-
strument and processed to obtain the diameter-BP curve as
well as the compliance-BP curve. To match the parameters
obtained with the plethysmographic method, the area under
the compliance-BP curve, defined over a standard range of
blood pressures (70–130 mmHg), was determined and de-
fined as “radial artery compliance” (RACAUC). In three of
these subjects, the between-method agreement was tested
considering the compliance changes during hyperemia, and,
in five other subjects, it was tested by evaluating the compli-
ance changes induced by glyceryl trinitrate (GTN) adminis-
tration. In these last experiments, after the baseline FACAUC
and RACAUC evaluations, two doses of sublingual GTN were
administered, and FACAUC and RACAUC were recorded after
4 min. In three of these subjects, the doses of GTN used were
25 and 50 mg; in the fourth subject, they were 50 and 100 mg;
and in the fifth subject, they were 200 and 400 mg.
Lipids. At the time of blood sampling for lipid analysis, the
subjects were on a free diet. Venous blood was collected from
the antecubital vein after an overnight fast and anticoagu-
lated with EDTA (1 mg/ml). Total cholesterol and triglycer-
ides were determined by enzyme methods (7, 29). High-
density lipoprotein cholesterol (HDL-C) was separated by
selective precipitation of ApoB-containing lipoproteins with
dextran-sulfate-MgCl2 (38). Plasma LDL-C levels were cal-
culated according to the Friedewald formula (15).
BP measurements. Heart rate, DBP, mean BP, and SBP
were continuously recorded from the middle finger of the
dominant arm using a Finapress instrument (2300 Finapress
blood pressure monitor, Ohmeda). This method provides ac-
curate continuous BP measurements comparable with intra-
arterial recordings (19, 26).
FAC measurements. The FAC of the nondominant arm was
measured by a previously described plethysmographic method,
which allows direct assessment of the nonlinear “FAC-BP
curve” relative to each single cardiac cycle (2). Briefly, mea-
surements of forearm pulse volume (FPV) were made by
means of the extensimetric hemofluximeter Angiomed (Mi-
crolab Electronic; Padua, Italy). A double-stranded loop of
fine-gauge silastic rubber tubing (internal diameter 0.5 mm,
external diameter 2.1 mm) containing gallium, indium, and
Table 1. Characteristics of the studied subjects
n 95
Age, yr 44.1616.9
Body mass index, kg/m2 24.463.7
Heart rate, beats/min 74.7613.5
SBP, mmHg 142.3619.9
DBP, mmHg 81.6610.9
Total cholesterol, mg/dl 217.1653.2
HDL-C, mg/dl 42.0620.4
LDL-C, mg/dl 144.7643.6
LDL-C/HDL-C 4.0964.87
Triglycerides, mg/dl 130 (29–594)
Results are expressed as means 6 SD except for triglycerides,
which are expressed as median and range; n, no. of subjects. SBP and
DPB, systolic and diastolic blood pressures (BP), respectively;
HDL-C and LDL-C, high- and low-density lipoprotein cholesterol,
respectively.
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tin was placed around the upper forearm. Simultaneous
recordings of FPV (Fig. 1, top) and BP (Fig. 1, bottom) were
used to establish the relationship between FPV and BP (Fig.
2, top). The mathematical model that fits best with these
experimental points is a logarithmic function mathemati-
cally expressed as
y 5 a 3 ln ~x! 2 b (1)
with correlation coefficients ranging from r 5 0.72 to 0.99. In
72.7% of the cases, the correlation coefficient was .0.9 (see
Fig. 2, top). a and b are the coefficients that fit best with the
experimental points. x and y are BP and FPV, respectively.
The slope of this function represents the nonlinear
FAC-BP curve (Fig. 2, bottom), mathematically calculated as
the first derivative of Eq. 1
y 5 a 3 1/x (2)
Thus, in our model, compliance is confirmed to have a
nonlinear dependence on pressure, decreasing with increas-
ing BP.
The distance between the site where the strain gauge was
positioned and the site where pulse pressure was recorded
creates a phase shift in the systodiastolic volume-pressure
relationship. It has been demonstrated that hysteresis re-
lated to the viscoelasticity of the vessel wall is negligible: the
observed phase shift is mainly due to the distance mismatch
and can be mathematically corrected (35), as performed by
us.
To obtain a comparison among patients in isobaric condi-
tions, FACAUC, defined over a standard range of BP (70–130
mmHg), was determined by calculating the integral, between
70–130 mmHg, of Eq. 2
y 5 a 3 ln ~130/70! (3)
After baseline measurements (average measurement of
16–25 beats obtained in 20 s), an ischemia occlusive test was
carried out by upper arm pressure cuff inflation, 30 mmHg
above the systolic pressure for 3 min. (In the group of 12
subjects enrolled to examine the possibility that the shape of
the time course curve may depend on the duration of ische-
mia, the ischemia occlusive test was carried out by cuff
inflation for both 3 and 12 min.)
After cuff deflation, the FPV and BP were continuously
recorded for an additional 5 min. The time course of postis-
chemic compliance changes was visualized by plotting the
postischemic FACAUC measurements (each FACAUC value is
the average of 4–5 beats) versus time (Fig. 3). Postischemic
compliance parameters such as peak FACAUC, percent
change, peak time, descent time, time of peak maintenance,
and reserve area were then calculated (24). The procedures
and formulas for the derivation of the postischemic parame-
ters are detailed in the APPENDIX.
A single observer performed all examinations after pa-
tients had rested supine for 15 min in a temperature-con-
trolled room at 26 6 2°C.
Statistical analyses. Mean 6 SD values were used as
descriptive measures of normally distributed variables; in
other cases, the median and range were used. Pre- and
postischemic FACAUC comparisons were done by a Wilcoxon
signed-rank test. Correlation analyses were performed using
parametric methods (Pearson’s moment correlation) after log
transformation of triglycerides and plethysmographic vari-
ables. Multiple stepwise regression analysis was used to
determine the relative importance of each variable (total
cholesterol, HDL-C, LDL-C, triglycerides, age, and body
mass index) in predicting pre- and postischemic FACAUC
parameters. Statistical significance was accepted at a value
of P , 0.05.
The method repeatability was evaluated by estimating the
coefficient of variation (CV) between plethysmographic val-
ues obtained during the initial and the respective replicate
measurements obtained after ;1 mo. CV was calculated
after the log transformation of the variables considered.
Fig. 2. Example of the pulse volume-BP relationship (top) and com-
pliance-BP curve (bottom) in the preischemic condition and at the
peak value during reactive hyperemia.
Fig. 1. Simultaneous recordings of the pulsatile change in the fore-
arm pulse volume (top) and hand finger arterial blood pressure (BP;
bottom) in the preischemic condition and at the peak value during
reactive hyperemia.
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The agreement between the plethysmographic and ultra-
sonic technologies was evaluated by estimating the consis-
tent bias between at least 36 compliance readings obtained
with the plethysmographic method versus the same readings
obtained with the echotracking device as recommended by
Bland and Altman (4). Each point considered in this analysis
was the mean compliance value obtained from at least 12
cardiac cycles. The coefficient of repeatability was calculated
according to the British Standards Institution (6) and corre-
sponds to 2 SD of the relative differences between replicate
measurements. In addition, correlation coefficients, CV (in
%), and the percent error between measurements were also
calculated.
RESULTS
FAC and reactive hyperemia. During reactive hyper-
emia, arterial BP did not change, whereas FPV in-
creased (Fig. 1). The rise of FPV produced a higher
slope of the FPV-BP curve and, as a consequence, an
increase in the FACAUC (Fig. 2).
Before arterial occlusion, FACAUC ranged between
1.85 3 1022 and 15.2 3 1022 with a median of 5.77 3
1022 ml z100 ml forearm21 zmmHg21 zmmHg. After cuff
deflation, FACAUC rose in all the subjects, reached a
maximum, and then tended to return to the baseline
levels in an asymptotic manner (Fig. 3). The median
percent change was rather variable from subject to
subject, ranging from 16.3 to 265.5%, with a median of
84% (P , 0.0001 vs. preischemia; Table 2).
Time course of FACAUC changes during reactive hy-
peremia. To assess the FACAUC closest to the real peak
value (“true peak value”), FACAUC measurements were
carried out continuously, and the time course of
FACAUC changes was defined. This protocol allowed
analyzing the shape of the time course curve, thus
providing the opportunity to understand whether the
peak FACAUC value was maintained for a time period
long enough to be detectable with noncontinuous mea-
surements. The time-dependent plethysmographic
characteristics of the 93 subjects studied are shown in
Table 2. FACAUC reached its maximal value ;17 s
Fig. 3. Typical example of a time course of compliance changes during reactive hyperemia showing the “true” area
under the forearm arterial compliance (FAC)-BP curve (FACAUC) maximal change not otherwise detectable with
noncontinuous measurements. Each FACAUC value is the average of 4–5 beats. a and b are coefficients of the
mathematical function that best fit with the descent time.
Table 2. Postischemic compliance characteristics
of the studied subjects
Peak FACAUC31022
Mean6SD 11.064.1
Median (range) 10.7 (3.80–23.40)
Percent change
Mean6SD 91.9649.7
Median (range) 84.0 (16.3–265.5)
Peak time, s
Mean6SD 16.0610.6
Median (range) 17.0 (2.0–52.0)
Time of peak maintenance, s
Mean6SD 5.266.3
Median (range) 2.5 (2.5–41.7)
Descent time, s
Mean6SD 67.8636.8
Median (range) 63.4 (8.2–196.5)
Reserve area, au
Mean6SD 1.961.1
Median (range) 1.7 (0.2–4.9)
FACAUC, area under the forearm arterial compliance (FAC)-BP
curve (in ml z100 ml forearm21 zmmHg21 zmmHg). au, Arbitrary
units.
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after cuff deflation (range, 2–52 s) and, in 77% of
subjects, was maintained for not more than 2.5–7 s, a
time interval too short for legitimate noncontinuous
measurements. Thus, in most subjects, descent starts
almost immediately, and FACAUC returns to its respec-
tive preischemic values in ;63 s (descent time range,
8–196 s).
Repeatability of pre- and postischemic plethysmo-
graphic variables. Table 3 shows the pre- and postis-
chemic plethysmographic variables obtained at the ini-
tial visit and after 1 mo in a subset of nine subjects; the
CVs are also reported. Whereas the CV was ,10% for
preischemic FACAUC, peak FACAUC and percent
change, it ranged between 16.2 and 62% for the time-
related variables.
Agreement between the plethysmographic method
and echotracking device in compliance determination.
The 12 subjects recruited for the agreement study had
a mean age (6SD) of 37 6 11 yr (range, 27–55 yr).
Eleven (92%) were males, and, with the exception of
two smokers and two hypertensives, none was exposed
to significant cardiovascular risk factors (e.g., blood
pressure, lipids, or diabetes).
Data included in the between-method analysis were
obtained by pooling all the compliance measurements
obtained in stimulated and unstimulated conditions,
with a total of 36 data analyzed. The area under the
compliance-BP curve ranged from 2.41 3 1022 to
6.73 3 1022 ml z100 ml forearm21 zmmHg21 zmmHg,
with a mean value of 4.15 3 1022 6 1.10 3 1022 ml z100
ml forearm21 zmmHg21 zmmHg, when measured with
the plethysmographic method and from 1.06 3 1022 to
5.64 3 1022 mm2 zmmHg21 z1023 zmmHg, with a mean
value of 3.27 3 1022 6 1.12 3 1022
mm2 zmmHg21 z1023 zmmHg, when measured with the
echotracking device. The bias between readings was
20.87 3 1022 6 0.61 3 1022, with a repeatability
coefficient of 2.13 3 1022 and limits of agreement
between the two systems ranging from 22.1 3 1022 to
0.35 3 1022 (Fig. 4, top). The mean absolute difference
between the two measurements was 0.93 3 1022 6
0.53 3 1022, with a CV of 11.7% and a correlation
coefficient of 0.85 (y 5 0.014 1 0.83x; P , 0.0001; Fig.
4, bottom).
Agreement between plethysmography and echotrack-
ing in assessment of compliance changes after GTN
administration. The FACAUC and RACAUC responses to
the two doses of sublingual GTN in the five subjects
selected for the GTN study are illustrated in Fig. 5. In
the three subjects treated with low doses of GTN (25
and 50 mg) and in the single subject treated with 50
and 100 mg of GTN, a dose-dependent increase of
RACAUC was observed. In contrast, in the single sub-
ject treated with the higher doses of GTN (from 200 to
400 mg), a dose-dependent reduction of RACAUC was
Table 3. Reproducibility of change in FAC during
reactive hyperemia
Baseline
(n 5 9)
1 Mo
(n 5 9)
CV,
%
Preischemic
FACAUC31022
Means6SD 5.8361.48 5.4361.71 7.9
Median (range) 5.94 (4.03–7.61) 5.77 (2.83–7.57)
Peak FACAUC31022
Means6SD 10.761.85 10.464.02 8.4
Median (range) 11.6 (7.91–12.6) 8.37 (6.68–16.2)
Percent change
Means6SD 90.0641.6 96.3657.7 8.8
Median (range) 76.2 (55.1–170.2) 98.8 (28.3–178.8)
Peak time, s
Means6SD 8.9768.12 4.8265.97 32.2
Median (range) 7.37 (1.9–22.2) 2.45 (1.2–16.9)
Time of peak
maintenance, s
Means6SD 5.767.8 3.963.4 47.3
Median (range) 2.5 (2.5–21.7) 2.5 (2.5–10.8)
Descent time, s
Means6SD 78.1623.4 54.6625.1 16.2
Median (range) 77.0 (43.7–111.5) 61.8 (8.9–76.3)
Reserve area, au
Means6SD 2.1261.06 1.3460.81 62
Median (range) 1.95 (0.93–3.82) 1.23 (0.37–2.65)
n, No. of subjects. FACAUC was measured in ml z100 ml
forearm21 zmmHg21 zmmHg. CV, coefficient of variation.
Fig. 4. Top: agreement between the plethysmographic and ultra-
sound technologies. The differences between measurements obtained
with the plethysmographic and with the ultrasound methods are
plotted versus their means. The mean difference and the limits of
agreement are also indicated. Bottom: relationship between mea-
surements obtained with the plethysmographic system and with
ultrasound technology. RACAUC, area under the radial artery com-
pliance (RAC)-BP curve.
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detected. All the compliance changes detected with the
echotracking system were also appreciated using the
plethysmographic device. Interestingly, although quite
different in terms of absolute values, the trends of the
compliance changes are substantially identical with
the plethysmographic method and with the echotrack-
ing device (Fig. 5).
Agreement between plethysmography and echotrack-
ing in assessment of compliance changes during reac-
tive hyperemia. The FACAUC and RACAUC responses to
reactive hyperemia in three subjects are shown in Fig.
6. Although not identical in absolute terms, the kinet-
ics of the compliance changes during reactive hyper-
emia are clearly appreciable using both the plethysmo-
graphic method and the echotracking device (Fig. 6).
Duration of ischemic test and shape of the time course
curve. In the 12 subjects enrolled to investigate whether
duration of arterial occlusion may influence the shape
of the time course curve, two complete plethysmo-
graphic examinations were performed at a 1-h interval.
The FACAUC changes obtained after 3 and 12 min of
arterial occlusion were then compared. As shown in
Table 4, a prolonged arterial occlusion clearly produced
higher values for each parameter considered. However,
the time required to reach the peak was again highly
variable (range, 2–27 s), and the time of peak mainte-
nance was again very brief, not exceeding, in 83% of
the cases, 14 s (range, 5–45 s).
Correlation between plethysmographic parameters
and laboratory and clinical variables. To investigate
whether the different postischemic plethysmographic
Fig. 5. Changes in area under the compliance-BP curve induced by
two doses of sublingual glyceryl trinitrate (GTN) as measured using
the plethysmographic method proposed here () as well as echotrack-
ing technology (F) in 5 control subjects.
Fig. 6. Time-course curve of compliance changes during reactive
hyperemia in 3 control subjects as measured using plethysmography
() and echotracking technology (F).
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parameters were related to laboratory and clinical
variables, a series of correlation analyses was per-
formed (Table 5). The peak FACAUC correlated in-
versely with SBP, whereas percent change correlated
inversely with LDL-C and the LDL-C-to-HDL-C ratio
and directly with HDL-C. Peak time correlated in-
versely with age and HDL-C, whereas descent time
and the reserve area correlated inversely with age and
log-transformed triglyceride content.
Multiple regression analyses. Table 6 shows a series
of five forward stepwise multiple regression analyses
performed using log-transformed plethysmographic
parameters as dependent variables and laboratory/
clinical variables as independent variables. In this
series of analyses, sex was the only parameter inde-
pendently associated with preischemic FACAUC (R2 5
0.19, P 5 0.001). Sex (directly) and SBP (inversely)
significantly predicted the peak FACAUC value (R2 5
0.26, P 5 0.0001 and P 5 0.01, respectively), whereas
HDL-C (directly) and total cholesterol (inversely) cor-
related independently with the percent change (R2 5
0.10, P 5 0.01 and P 5 0.04, respectively). Finally, age
(inversely) and body mass index (directly) correlated
with the peak time (R2 5 0.13, P 5 0.003 and P 5 0.02,
respectively), whereas log-transformed triglyceride
content was the only independent predictor of descent
time (R2 5 0.09, P 5 0.005).
Plethysmographic parameters and lipid tertiles. To
further investigate the impact of plasma lipid/lipopro-
tein levels in predicting pre- and postischemic plethys-
mographic variables, the data were stratified into ter-
tiles according to HDL-C, LDL-C, triglycerides, and the
LDL-C-to-HDL-C ratio (Table 7). According to what
was observed in the correlation analysis, the percent
changes increased and peak time decreased with rising
HDL-C levels. In contrast, the percent changes de-
creased with rising LDL-C levels and LDL-C-to-HDL-C
ratios. As far as time-related variables are concerned,
descent time and the reserve area significantly de-
creased with rising triglyceride values.
DISCUSSION
A number of studies performed using high-resolution
ultrasound methods to assess arterial compliance
(measurements of finger BP and radial artery diame-
ter, allowing the analysis of the diameter-pressure
curve) have shown that compliance increases markedly
after prolonged ischemia, thus allowing the study of
reserve above baseline (18). In the present study, it is
also clearly substantiated that with the proposed ple-
thysmographic method, based on continuous measure-
ments of finger BP and FPV (FPV is the result of
changes at the level of large and small vessels level),
postischemic compliance modifications occurring dur-
ing reactive hyperemia can be detected even after only
3 min of arterial occlusion. Despite the high interindi-
vidual variability in the preischemic FACAUC value, all
patients show, after cuff deflation, a significant in-
crease in FACAUC, with percent changes ranging from
16.3 to 265.5%.
To the best of our knowledge, this is also the first
study attempting to explore the kinetics of compliance
modification using a continuous measurement ap-
proach, thus allowing the evaluation of the validity of
noncontinuous measurement procedures often used, by
others, to study compliance changes in the course of
reactive hyperemia. The present findings clearly show
that FACAUC changes during reactive hyperemia are
strongly related to the time factor. Thus, according to
the present results, a noncontinuous measurement
procedure may be questionable. These findings, in fact,
not only show that the time required to reach the peak
value (peak time) is quite variable, ranging from sub-
ject to subject from 2 to 52 s, but also, and more
important, that the peak value is maintained for a time
period too short (,7 s in ;77% of cases) to be assessed
by measurements carried out at arbitrary time inter-
vals. After a defined interval from cuff deflation, i.e.,
30 s, measured values may not be representative of the
Table 5. Correlation coefficients among log-
transformed postischemic compliance parameters
and lipid and anamnestic variables
Peak
FACAUC
Percent
Change
Peak
Time
Descent
Time
Reserve
Area
Age NS NS 20.20* 20.20* 20.25†
SBP 20.20* NS NS NS NS
DBP NS NS NS NS NS
Total cholesterol NS NS NS NS NS
Log triglycerides NS NS NS 20.31† 20.27†
HDL-C NS 0.23* 20.20* NS NS
LDL-C NS 20.22* NS NS NS
LDL-C/HDL-C NS 20.32† NS NS NS
NS, not significant. *P , 0.05; †P , 0.01.
Table 4. Plethysmographic characteristics before and
after 3 or 12 min of arterial occlusion
Arterial Occlusion
3 Min 12 Min
Preischemic FACAUC31022
Means6SD 6.4663.22 6.4263.02
Median (range) 5.51 (2.21–14.1) 6.21 (2.43–13.5)
Peak FACAUC31022
Means6SD 16.668.74 25.9614.8
Median (range) 13.4 (4.66–35.7) 21.6 (9.58–62.1)*
Percent change
Means6SD 160670 3016100
Median (range) 171 (56–261) 314 (157–441)*
Peak time, s
Means6SD 463 1269
Median (range) 3 (2–12) 8 (2–27)*
Time of peak maintenance, s
Means6SD 5.768.7 11.4613.6
Median (range) 2.5 (2.5–32.5) 4.7 (2.5–42.0)*
Descent time, s
Means6SD 64629 130650
Median (range) 66 (19–109) 109 (73–209)*
Reserve area, au
Means6SD 2.7961.94 11.4466.56
Median (range) 1.84 (0.65–5.56) 11 (2.33–23.84)*
FACAUC was measured in ml z100 ml forearm21 zmmHg21 zmmHg.
*P , 0.01 by Wilcoxon signed-rank test.
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true peak but, more likely, provide a simple estimate of
the ascent or descent phases of the time course curve
(Fig. 7). The concept that a noncontinuous measure-
ment procedure may be questionable is also underlined
by the fact that methodological repeatability is clearly
lower for time-related variables versus FACAUC and
percent change values (Table 3).
The reasons for the elevated between-patient vari-
ability in the time course compliance parameters re-
ported here are not clear. Variability may reflect prom-
inent influences not controlled for, such as neural
effects, humoral stimuli, or regional metabolic
changes. In addition, biological variability may, of
course, be partially contributory. The presence of vas-
cular risk factors, as well as a possible influence of
flow-mediated vasodilatation on the time course com-
pliance parameters, may further contribute to the de-
scribed variability. Independent of the mechanism(s) of
a such striking variability, the present results strongly
advocate that, to determine true maximal changes of
arterial compliance during reactive hyperemia, a con-
tinuous measurement is more appropriate. A possible
criticism to this conclusion might be that only 3 min of
arterial occlusion are too brief a stimulus to induce
maximal compliance changes. Ischemia was limited to
3 min because the subject’s pain, frequently resulting
from a more prolonged ischemia, was a clear limiting
factor. However, in the 12 subjects in whom 3 and 12
min of arterial occlusion were compared, we observed
that, although 12 min of arterial occlusion effectively
produced higher values for each parameter considered,
the peak time was again too variable and the time of
peak maintenance too brief to allow acceptance of non-
continuous measurements. Thus, in performing 12 min
of arterial occlusion, a continuous measurement proce-
dure also seems to be essential (at least for the first 1
or 2 min after cuff deflation) to identify the true peak
FACAUC value.
Another important reason to determine the time
course curve derives from the fact that this procedure
may provide, in addition to maximal FACAUC, other
time-dependent compliance parameters potentially
useful to better characterize possible endothelial dys-
function. This hypothesis is supported by previous
studies (20, 34) in human peripheral conduit arteries
suggesting that, whereas nitric oxide is minimally in-
volved in regulating forearm blood flow at peak reac-
tive hyperemia, it plays a significant role in maintain-
ing vasodilatation during the post-peak phase. On the
basis of these findings, one may assume that the
marked increases in forearm blood flow during the
early phases of reactive hyperemia can induce in-
creased shear stress, which may release nitric oxide
from the endothelium, thus contributing to vasodilata-
tion and possibly compliance modulation during the
mid to late phase of reactive hyperemia. The mecha-
nisms by which the endothelium, or perhaps endothe-
lium-derived nitric oxide, can modulate the postische-
mic time-dependent compliance parameters were not
investigated in this study. One may, however, specu-
late that local factors contributing to flow-mediated
vasodilatation of microvessels, such as changes in in-
terstitial potassium and hydrogen ions, osmolality,
carbon dioxide, catecholamines, prostaglandins, and
adenosine (1, 5, 8, 12, 20, 23, 25), can also be involved
in the regulation of the parameters considered here.
Although we cannot be sure about the endothelium-
dependent nature of these parameters, it is interesting
to note that some of them are markedly correlated with
well-known traditional risk factors for endothelial dys-
function, such as age (9, 11, 16), high cholesterol (17,
33, 37), and triglycerides (28) (Table 5); such findings
were also confirmed after stratification of the studied
group into tertiles for lipid variables (Table 7).
Most of the studies published so far evaluating the
effects of vascular risk factors on vasoactivity after
Table 6. Forward stepwise multiple regression analysis
Correlated
Independent Variables R2 R2 Adjusted b b (SE) 95% Confidence Interval P
Preischemic FACAUC
Sex 0.1919 0.1604 0.26990 0.07798 0.11462 0.42518 0.001
Peak FACAUC
Sex 0.2586 0.2195 0.33875 0.07654 0.18632 0.49119 0.0001
SBP 20.00728 0.00274 20.01274 20.00183 0.01
Percent change
HDL-C 0.1027 0.0797 0.00817 0.00315 0.00190 0.01444 0.011
LDL-C 20.00254 0.00121 20.00494 20.00014 0.038
Peak time
Age 0.1296 0.1073 20.01979 0.00632 20.03237 20.00721 0.003
Body mass index 0.07203 0.02931 0.01367 0.13038 0.016
Descent time
Log triglycerides 0.0947 0.0832 20.00197 0.00068 20.00333 20.00060 0.005
The following dependent variables were log transformed: preischemic FACAUC, peak FACAUC, percent change, peak time, and descent time.
The following laboratory and clinical variables were considered in the models: sex, age, body mass index, DBP, SBP, total cholesterol, log
triglycerides, HDL-C, and LDL-C. b, Coefficient of the mathematical function that best fits with the descent time.
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arterial occlusive stimuli have been carried out com-
pletely ignoring time factors. To the best of our knowl-
edge, the only study (32) that evaluated the effects of a
major vascular risk factor (cigarette smoking) on vaso-
activity using continuous measurements showed im-
proved measurement accuracy and an improved possi-
bility of uncovering arterial functional abnormalities
in smokers not otherwise detectable when the “time”
factor is ignored. Thus vascular risk factors may mod-
ulate postischemic compliance changes, affecting not
only the degree of reactive response, but also overall
duration, or even both of these aspects. The present
results provide further support to this hypothesis. In
fact, when analyzing the cardiovascular risk factors of
the examined patient series, it becomes apparent that,
whereas reduced HDL-C levels may affect vasoactivity
by reducing percent changes and delaying the time
necessary to reach peak values, age seems to act only
by affecting time-dependent parameters. Thus, accord-
ing to Stadler et al. (32, 37), considering time-depen-
dent parameters, one can appreciate the effects of
vascular risk factors not otherwise detectable by con-
sidering percent changes only. The direct correlation
between percent changes and HDL-C and the inverse
correlation between percent changes and LDL-C or
LDL-C-to-HDL-C ratios confirm, also in this nonse-
lected group of subjects, a positive role for HDL-C (21,
22, 28) and a negative role for hypercholesterolemia on
endothelial function (2, 17, 33). After adjustment of
data for the other variables considered, in multiple
stepwise regression analysis (Table 6), sex was the only
variable independently related to the preischemic
FACAUC thus explaining ;19% (R2 5 0.19) of variabil-
ity. Sex and SBP independently correlated with peak
Fig. 7. Time course curves of 3 subjects. After a definite time interval
(i.e., 30 s), the measured compliance value may correspond to the
true maximal compliance change (curve A) but also to a simple value
of the ascent (curve B) or descent phase (curve C).
Table 7. Postischemic compliance characteristics after stratification of subjects into tertiles
of HDL-C, LDL-C, triglycerides, and LDL-C/HDL-C ratio
HDL-C LDL-C Triglycerides LDL-C/HDL-C
1st Tertile 3rd Tertile 1st Tertile 3rd Tertile 1st Tertile 3rd Tertile 1st Tertile 3rd Tertile
HDL-C, mg/dl 18.166.5 64.668.8 40.3621.9 43.5617.7 51.6618.9 32.3617.2 61.9611.1 21.1610.2
LDL-C, mg/dl 134.6648.1 142.8641.4 97.7616.7 192.0628.3 130.0637.3 158.0645.9 122.7631.2 156.2648.2
Triglycerides, mg/dl 197.06115.3 100.2641.4‡ 130.26105.5 169.3691.6 74.1617.6 254.36109.8 118.76103.0 206.86109.8‡
LDL-C/HDL-C 8.665.1 2.360.8 3.662.5 6.065.2 2.061.5 7.265.7 2.060.5 8.964.9
Peak FACAUC31022
Means6SD 10.863.5 10.564.4 11.464.3 10.863.8 10.864.6 10.963.7 11.664.5 11.463.5
Median
(range)
9.8
(5.0–19.7)
9.3
(4.2–22.8)
10.6
(5.0–22.8)
11.2
(3.8–21.3)
9.3
(5.0–22.8)
10.7
(3.8–19.2)
11.7
(5.2–22.8)
10.9
(6.6–19.7)
Percent change
Means6SD 72.9641.4 104.7657.3* 104.1660.1 77.1636.0* 91.0635.6 80.9647.4 113.7656.2 73.5639.4†
Median
(range)
59.0
(21.9–169.3)
94.0
(16.3–265.5)
84.0
(32.1–165.5)
76.0
(16.3–176.6)
84.0
(35.1–169.3)
74.0
(21.9–221.5)
105.0
(32.1–265.5)
65.0
(21.9–176.6)
Peak time, s
Means6SD 17.7610.9 13.8612.8* 13.269.8 16.569.7 17.4612.2 15.268.3 12.4611.4 17.169.8
Median
(range)
17
(2–52)
7
(1–47)
12
(2–42)
17
(2–47)
17
(2–47)
17
(2–37)
7
(1–42)
17
(2–52)
Time of peak
maintenance, s
Means6SD 5.764.9 3.161.6 4.964.4 6.368.7 4.364.6 6.768.3 3.361.8 5.164.4
Median
(range)
3
(3–18)
3
(3–8)
3
(3–18)
3
(3–42)
3
(3–22)
3
(3–42)
3
(3–8)
3
(3–18)
Descent time, s
Means6SD 63.8638.4 67.12633.7 68.3634.2 64.0631.3 77.5629.1 53.9628.6‡ 66.7632.4 57.3633.6
Median
(range)
70
(8–140)
58
(13–128)
69
(8–140)
54
(13–132)
78
(14–123)
53
(8–112)
63
(14–128)
53
(8–139)
Reserve area, au
Means6SD 1.5460.89 1.8361.21 1.8760.94 1.6661.03 2.1361.06 1.5261.04* 2.0761.28 1.4860.88
Median
(range)
1.34
(0.34–3.59)
1.67
(0.38–4.88)
1.79
(0.38–3.70)
1.25
(0.36–3.82)
2.27
(0.50–4.38)
1.22
(0.34–3.81)
1.88
(0.45–4.88)
1.33
(0.34–3.35)
Second Tertiles have been omitted to exclude patients with borderline values of the variables listed. FACAUC was measured in ml z100 ml
forearm21 zmmHg21 zmmHg. *P , 0.05, †P , 0.01, and ‡P , 0.001 vs. 1st tertiles by Student’s t-test after log transformation of
plethysmographic variables.
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FACAUC and together explained ;26% (R2 5 0.26) of
variability. Peak time was mainly affected by age and
body mass index (R2 5 0.13), whereas lipid variables
affected mainly the percent change, significantly and
independently correlated with plasma levels of HDL-C
(directly) and LDL-C (inversely), and descent time, this
last mainly affected by plasma levels of triglycerides.
As far as the reserve area is concerned, the correlations
observed with the linear regression analysis did not
reach statistical significance after data adjustment for
the other variables considered. Another interesting
finding that can be deduced from our results is that
descent time seems to be related to the presence of
pathological conditions when it is reduced, whereas the
same is true for the prolongation of peak time. This
suggestion is well supported not only by the inverse
correlation between peak time and HDL-C, a well-
known protective lipoprotein parameter (21, 22, 28),
but also by the same negative correlation with percent
changes of arterial compliance (20.38, P , 0.001),
known to be reduced when vascular risk factors or
pathological conditions are present.
All of these results strongly advocate the use of the
plethysmographic method proposed here as a useful
tool to measure arterial compliance in vivo. Because
more extensive background information was needed to
validate its ability to provide measurements applicable
to clinical trials, a study was performed comparing the
method proposed here with the echotracking system, a
more widely accepted ultrasonic approach often ap-
plied to clinical trials (17, 19).
A high between-methods correlation coefficient was
observed (r 5 0.85, Fig. 4); however, by following the
analytical approach proposed by Bland and Altman (4),
the most appropriate method for evaluating the consis-
tency of a new method of measurement versus an
established one, it became apparent that the two meth-
ods can result in a discrepancy in arterial compliance
of about 20.87 3 1022. Thus, whereas the plethysmo-
graphic method may not be considered as interchange-
able with the echotracking one, both provide essen-
tially the same kind of information. Indeed, as
documented in Figs. 5 and 6, although different in
terms of absolute values, the trends of compliance
changes during reactive hyperemia as well as those
induced by sublingual GTN are essentially identical for
the two methods, thus indicating that the plethysmo-
graphic method described here provides reliable tech-
nology for arterial compliance measurements applica-
ble to clinical trials.
In conclusion, the proposed technique appears to be
highly sensitive and may be considered, as an alterna-
tive to ultrasound, as a potentially useful tool to detect
and monitor in vivo compliance changes induced by
arterial occlusion. In addition, the study strongly sug-
gests that the time factor should not be underesti-
mated when postischemic variables are considered. It
may, in fact, provide further time-dependent markers
enabling the objective assessment of the effects of risk
factors, and perhaps of risk factor modifications, on
compliance changes during reactive hyperemia, a stim-
ulus often used in pharmacological and clinical trials to
investigate, in a completely noninvasive way, arterial
endothelial dysfunction in humans.
APPENDIX
The peak area under the forearm arterial compliance
(FAC)-blood pressure (BP) curve (peak FACAUC) was the
maximal FACAUC value obtained after cuff deflation, and the
peak time was the time required to reach the peak value.
Time of peak maintenance was calculated as the difference
between the time where the descent phase starts and peak
time, whereas the descent time was the time required to
return within 10% of the baseline value calculated using the
following formula
descent time10% 5 ~FAC~AUC!10%/a!
~1/b! (A1)
where a and b are the coefficients of the mathematical func-
tion that best fits with the experimental points of the descent
phase (see Fig. 3), mathematically expressed as
y 5 ax(2b) (A2)
The percent change was calculated as follows: (peak
FACAUC/preischemic FACAUC 3 100) 2 100, whereas the
reserve area was the area under the time course curve minus
the baseline area.
The area under the time course curve was calculated by
adding the areas under the graph between each pair of
consecutive FACAUC measurements (24) with the measure-
ments y1 and y2 at times t1 and t2; the area under the curve
between those two times was the product of the time differ-
ence and the average of the two measurements. Thus we get
[(t2 2 t1) (y1 1 y2)]/2, i.e., fitting with the trapezium rule. If
we have n 1 1 measurements of y1 at time ti (i 5 0, . . ., n),
then the area under the curve (AUC) can be calculated as
AUC 5
1
2 (
i 5 0
n 2 1
@~ti 1 1 2 ti!~yi 1 yi 1 1!# (A3)
The baseline area was calculated as the product of the
preischemic FACAUC value and total time, calculated by
adding peak time, time of peak maintenance, and descent
time (Fig. 3), i.e., baseline area 5 preischemic FACAUC 3
(peak time 1 time of peak maintence 1 descent time).
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